This is a non-core endpoint: only basic statistics are computed.
Malignant neoplasm of other and unspecified parts of biliary tract
C3_BILIARY_TRACT
biliary tract neoplasm: A neoplasm that involves the biliary tract.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
656 |
4. Check minimum number of eventsNone |
656 |
5. Include endpointsNone |
656 |
6. Filter based on genotype QC (FinnGen only) |
593 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of other and unspecified parts of biliary tract
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo
- Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder
- Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo
- Malignant neoplasm of digestive organs
- Malignant neoplasm of digestive organs, including Hilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 593 | 251 | 342 |
| Unadjusted period prevalence (%) | 0.13 | 0.09 | 0.16 |
| Median age at first event (years) | 71.96 | 71.31 | 72.43 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 611
- Matched controls
- 6110
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H02AB02
ATC
dexamethasone; systemic
122.9
307.7
240
32
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
115.6
307.7
180
22
A03FA01
ATC
metoclopramide; systemic, rectal
22.4
307.7
368
387
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
91.7
307.7
172
26
UJK02
NOMESCO Finland
ERCP
63.7
307.7
224
55
K83.1
ICD-10 Finland
Obstruction of bile duct
225.4
307.7
218
15
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
122.6
307.7
169
19
Z51.5
ICD-10 Finland
Palliative care
39.1
307.7
290
138
130
Kela drug reimbursment
Malignant tumour
+∞
307.7
397
*
C24.9
ICD-10 Finland
Malignant neoplasm: Biliary tract, unspecified
+∞
248.4
221
*
A09AA02
ATC
multienzymes (lipase, protease etc.); oral
51.5
246.7
146
37
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
93.1
239.2
126
17
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
58.9
234.3
134
29
JKE02
NOMESCO Finland
Transduodenal endoscopic incision of common bile duct orifice
51.7
227.5
134
33
WX302
NOMESCO Finland
Thoracal epidural anesthesy
37.8
221.9
143
49
JN4AD
NOMESCO Finland
Body CT examination
16.2
218.8
222
208
N02AA05
ATC
oxycodone; systemic
11.8
217.4
353
633
A04AA02
ATC
granisetron; systemic, transdermal
2864.2
206.4
188
*
K83.0
ICD-10 Finland
Cholangitis
62.0
205.8
116
23
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
53.4
201.0
117
27
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
64.4
198.6
111
21
A04AA01
ATC
ondansetron; systemic, rectal
28.5
194.3
138
62
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
2517.3
189.9
174
*
L01BC06
ATC
capecitabine; oral
+∞
189.8
172
*
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
369.1
189.6
182
7
JLC30
NOMESCO Finland
Pancreatoduodenectomy
+∞
164.2
150
*
C22.1
ICD-10 Finland
Malignant neoplasm: Intrahepatic bile duct carcinoma
+∞
156.1
143
*
C24.0
ICD-10 Finland
Malignant neoplasm: Extrahepatic bile duct
+∞
142.4
131
*
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
38.9
138.9
87
26
JN4BD
NOMESCO Finland
Extensive body CT
13.2
129.9
137
131
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
20.4
128.5
103
60
JN4CD
NOMESCO Finland
Very extensive body CT
31.7
127.5
85
31
8160/3-C24.9
ICD-O-3
Cholangiocarcinoma of billiary tract, NOS
+∞
124.3
115
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
123.2
114
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
9.6
120.6
166
228
C24.1
ICD-10 Finland
Malignant neoplasm: Ampulla of Vater
+∞
117.6
109
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
116.5
108
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
21.4
115.5
90
49
JN3AD
NOMESCO Finland
Abdominal CT examination
7.5
110.4
200
373
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
1248.7
110.0
104
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
107.5
100
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
12.4
104.2
112
109
8000/3-C24.9
ICD-O-3
Neoplasm, malignant of billiary tract, NOS
+∞
103.1
96
*
C24.09
ICD-10 Finland
Biliary duct or passage NOS
+∞
99.8
93
*
JK3BT
NOMESCO Finland
Catherisation of bile duct with X-ray guidance
348.2
90.4
89
*
JAH01
NOMESCO Finland
Laparoscopy
13.7
90.3
89
75
8140/3-C24.1
ICD-O-3
Adenocarcinoma, NOS, of ampulla of Vater
+∞
89.8
84
*
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
22.0
88.2
67
34
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
9.3
86.7
115
148
WZC00
NOMESCO Finland
Treatment plan or consultation
5.0
86.1
305
1012
C24.02
ICD-10 Finland
Common bile duct
+∞
85.5
80
*
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
30.7
84.0
56
20
A49.9
ICD-10 Finland
Bacterial infection, unspecified
6.1
83.5
179
386
C24.00
ICD-10 Finland
Hepatic duct
+∞
82.2
77
*
R4190
NOMESCO Finland
Nutritional therapy
16.2
77.0
68
47
R50.9
ICD-10 Finland
Fever, unspecified
5.3
72.5
188
475
WZC30
NOMESCO Finland
Teaching
5.3
69.2
172
418
8160/3-C24.0
ICD-O-3
Cholangiocarcinoma of extrahepatic bile duct
+∞
69.1
65
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.5
68.0
162
379
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
62.6
59
*
C24.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of biliary tract
+∞
61.5
58
*
XX3DW
NOMESCO Finland
Time consuming IT work
8.3
61.3
87
120
8140/3-C24.0
ICD-O-3
Adenocarcinoma, NOS, of extrahepatic bile duct
+∞
58.3
55
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
12.0
58.1
61
56
A04AA55
ATC
palonosetron, combinations; systemic
+∞
57.2
54
*
JKE22
NOMESCO Finland
Endoscopic extraction of foreign body from bile duct
132.8
56.9
60
5
JN3BD
NOMESCO Finland
Extensive abdominal CT
5.5
56.9
128
282
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
8.2
54.6
77
105
WW500
NOMESCO Finland
Blood transfusion
12.2
54.3
56
50
JK3NB
NOMESCO Finland
Percutaneous transhepatic cholangiography
552.8
52.3
51
*
B01AB10
ATC
tinzaparin; parenteral
5.4
52.1
116
252
WX402
NOMESCO Finland
General anaesthesia
4.0
51.1
186
596
TPH04
NOMESCO Finland
Cathetrisation of vein
3.8
50.6
222
807
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
48.6
46
*
TPH07
NOMESCO Finland
Cathetrisation of artery
4.4
45.7
136
373
JAH00
NOMESCO Finland
Laparotomy
10.6
45.1
51
52
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
9.6
44.3
54
61
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
+∞
44.3
42
*
8000/3-C24.0
ICD-O-3
Neoplasm, malignant of extrahepatic bile duct
+∞
44.3
42
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
458.8
43.8
43
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
43.2
41
*
JK4ZT
NOMESCO Finland
Percutaneous transhepatic implantation of bile duct prothesis
+∞
43.2
41
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
43.2
41
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
12.4
42.5
43
37
8140/3-C24.9
ICD-O-3
Adenocarcinoma, NOS, of billiary tract, NOS
+∞
42.2
40
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
42.2
40
*
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
72.5
41.7
47
7
JKE32
NOMESCO Finland
Endoscopic dilatation of bile duct
153.9
41.3
43
*
JK3FT
NOMESCO Finland
Exchange of bile duct catheter with radiological guidance
+∞
37.9
36
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
37.9
36
*
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
+∞
37.9
36
*
R18
ICD-10 Finland
Ascites
11.8
37.5
39
35
A06AH03
ATC
naloxegol; oral
74.9
37.4
42
6
C23
ICD-10 Finland
Malignant neoplasm of gallbladder
+∞
36.8
35
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
378.6
36.4
36
*
J01MA12
ATC
levofloxacin; systemic
3.2
34.3
178
697
B01AB05
ATC
enoxaparin; parenteral
2.9
33.6
248
1179
L03AA02
ATC
filgrastim; parenteral
344.8
33.2
33
*
K83.9
ICD-10 Finland
Disease of biliary tract, unspecified
51.9
32.9
39
8
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
29.4
28
*
ZX120
NOMESCO Finland
Intravenous
4.4
29.0
78
195
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
108.7
28.9
31
*
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
+∞
26.2
25
*
JKE25
NOMESCO Finland
Endoscopic external drainage of bile duct
+∞
26.2
25
*
A04AD12
ATC
aprepitant; systemic
+∞
26.2
25
*
A02BC02
ATC
pantoprazole; systemic
2.8
26.2
464
3250
ZXE30
NOMESCO Finland
More than five and less than seven hours
5.9
25.8
48
87
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
73.1
25.0
28
*
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
30.6
24.3
32
11
JK3NT
NOMESCO Finland
Percutaneous transhepatic dilatation of bileducts
+∞
24.1
23
*
A06AD11
ATC
lactulose; oral
2.8
24.1
156
676
A05AA02
ATC
ursodeoxycholic acid; oral
19.5
23.3
35
19
B01AB04
ATC
dalteparin; parenteral
5.0
23.1
52
112
A79
ICPC
Malignancy NOS
+∞
23.1
22
*
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
36.6
22.2
28
8
UJK12
NOMESCO Finland
Peroral cholangioscopy
65.0
22.0
25
*
WX004
NOMESCO Finland
Patient-controlled sedation
119.3
21.7
23
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.5
21.7
170
805
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
52.0
21.3
25
5
WF002
NOMESCO Finland
Radical radiotherapy
62.3
21.0
24
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
21.0
20
*
C24.01
ICD-10 Finland
Cystic duct
+∞
21.0
20
*
D77
ICPC
Malignant digestive neopl other/NOS
217.1
20.7
21
*
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.6
20.4
140
620
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.2
20.3
343
2239
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
7.3
20.1
30
43
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
59.6
20.0
23
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
59.6
20.0
23
*
116
Kela drug reimbursment
Prostate cancer
+∞
19.9
19
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
19.9
19
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.5
19.0
153
729
C17.0
ICD-10 Finland
Malignant neoplasm: Duodenum
+∞
18.8
18
*
8160/3-C22.1
ICD-O-3
Cholangiocarcinoma of intrahepatic bile duct
+∞
18.8
18
*
K85.8
ICD-10 Finland
Other acute pancreatitis
24.6
18.8
26
11
ZXE40
NOMESCO Finland
More than seven and less than nine hours
7.4
18.4
27
38
WVA20
NOMESCO Finland
Medicine administration
5.5
18.2
36
69
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
17.8
17
*
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
32.5
17.1
22
7
A41.8
ICD-10 Finland
Other specified sepsis
5.9
17.0
31
55
JKA20
NOMESCO Finland
Cholecystectomy
5.2
16.9
35
70
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
7.1
15.8
24
35
WW200, ,
SPAT
0.3
15.8
54
1433
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
15.7
15
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
15.7
15
*
R93.2
ICD-10 Finland
Abnormal findings on diagnostic imaging of liver and biliary tract
19.9
15.7
23
12
L03AA13
ATC
pegfilgrastim; parenteral
87.4
15.6
17
*
JDE00
NOMESCO Finland
Gastrojejunostomy
164.0
15.5
16
*
WPB10
NOMESCO Finland
Making a convalescent care decision
39.2
15.5
19
5
D70.82
ICD-10 Finland
Drug-induced neutropenia
39.2
15.5
19
5
WX704
NOMESCO Finland
Intubation
3.3
15.4
61
198
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.5
15.4
113
512
JKE12
NOMESCO Finland
Endoscopic extraction of calculus from bile duct
6.7
15.0
24
37
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
15.0
209
1231
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
6.3
14.8
25
41
K75.0
ICD-10 Finland
Abscess of liver
25.8
14.8
20
8
D76
ICPC
Malignant neoplasm pancreas
+∞
14.6
14
*
B03XA02
ATC
darbepoetin alfa; parenteral
6.6
14.2
23
36
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
4.4
14.1
36
86
WX892
NOMESCO Finland
Monitored bed care
2.9
13.9
70
262
K90.3
ICD-10 Finland
Pancreatic steatorrhoea
20.6
13.9
20
10
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
5.0
13.7
30
63
J01MA02
ATC
ciprofloxacin; systemic
1.9
13.6
264
1732
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
13.6
13
*
JKC30
NOMESCO Finland
Partial excision of bile duct and anastomosis to jejunum
+∞
13.6
13
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
13.6
13
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
13.6
13
*
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
0.3
13.4
37
1114
WX725
NOMESCO Finland
Noninvasive ventilation
3.4
13.1
48
148
JA3BT
NOMESCO Finland
Cathetrisation of abdominal cavity with X-ray guidance
71.4
12.6
14
*
JLB28
NOMESCO Finland
Endoscopic internal drainage of pancreatic duct
71.4
12.6
14
*
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
+∞
12.5
12
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
12.5
12
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
12.5
12
*
C10AA07
ATC
rosuvastatin; oral
0.4
12.0
76
1560
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
47.6
11.9
14
*
WPA15
NOMESCO Finland
Palliative care consultation with the patient and loved ones
47.6
11.9
14
*
JK3SB
NOMESCO Finland
Endoscopic retrorade cholangiography
30.7
11.7
15
5
JJ1CE
NOMESCO Finland
Liver, bile duct and pancreas endoscopic ultrasound examination
30.7
11.7
15
5
R4110
NOMESCO Finland
Physiotherapy
2.0
11.6
171
1013
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
11.5
11
*
115
Kela drug reimbursment
Breast cancer
+∞
11.5
11
*
JL5CG
NOMESCO Finland
Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet
12.1
11.4
20
17
N02AX02
ATC
tramadol; systemic, rectal
1.8
11.3
271
1870
K80.5
ICD-10 Finland
Calculus of bile duct without cholangitis or cholecystitis
3.8
11.2
35
97
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
4.1
11.1
31
79
WX002
NOMESCO Finland
Sedation and analgesia
2.0
11.0
134
740
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
12.2
10.9
19
16
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
3.9
10.7
32
86
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
10.3
10.6
20
20
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
111.9
10.4
11
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
10.4
10
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
10.4
10
*
JLB12
NOMESCO Finland
Transduodenal endoscopic incision of pancreatic duct orifice
+∞
10.4
10
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
10.4
10
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
10.4
10
*
K83.8
ICD-10 Finland
Other specified diseases of biliary tract
33.1
10.4
13
*
K76.9
ICD-10 Finland
Liver disease, unspecified
8.7
10.1
21
25
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
5.1
10.1
21
42
SPAT1255
SPAT
Intravenous administration of medicine
2.7
10.1
55
214
WX882
NOMESCO Finland
High dependency care
4.0
10.0
28
72
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.1
9.9
109
580
WPA45
NOMESCO Finland
Continuous drug infusion in palliative care
55.9
9.7
11
*
D13
ICPC
Jaundice
55.9
9.7
11
*
K81.0
ICD-10 Finland
Acute cholecystitis
4.2
9.5
25
61
JJB50
NOMESCO Finland
Excision of segments V, VI, VII and VIII of liver
101.6
9.4
10
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
101.6
9.4
10
*
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
+∞
9.4
9
*
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
+∞
9.4
9
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
9.4
9
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
9.4
9
*
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
8.5
9.1
19
23
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
9.2
9.1
18
20
L02AE02
ATC
leuprorelin; implant, parenteral
37.3
9.0
11
*
ZXE20
NOMESCO Finland
More than three and less than five hours
2.2
9.0
83
411
A10AB05
ATC
insulin aspart; parenteral
2.4
9.0
62
271
K80.0
ICD-10 Finland
Calculus of gallbladder with acute cholecystitis
2.9
8.9
42
151
A41.9
ICD-10 Finland
Sepsis, unspecified
3.2
8.8
36
119
D02
ICPC
Abdominal pain epigastric
2.8
8.7
43
159
WPA44, ,
SPAT
20.4
8.5
12
6
Y77
ICPC
Malignant neoplasm prostate
91.3
8.4
9
*
XX4AT
NOMESCO Finland
Other canalization with ultrasound guidance
91.3
8.4
9
*
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
5.0
8.4
18
37
C26.9
ICD-10 Finland
Malignant neoplasm: Ill-defined sites within the digestive system
+∞
8.3
8
*
JKD20
NOMESCO Finland
Anastomosis of bile duct to jejunum
+∞
8.3
8
*
JJ3AT
NOMESCO Finland
Cytology of liver with ultrasound guidance
+∞
8.3
8
*
C25
ICD-10 Finland
Malignant neoplasm of pancreas
+∞
8.3
8
*
C80.92
ICD-10 Finland
Malignant tumor without specified localization adenocarcinoma
+∞
8.3
8
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
8.3
8
*
M79.6
ICD-10 Finland
Pain in limb
0.6
8.0
122
1906
I81
ICD-10 Finland
Portal vein thrombosis
13.2
7.9
13
10
EB1VA, ,
NOMESCO Finland
0.3
7.8
17
597
JK3MB
NOMESCO Finland
Postoperative cholangiography
45.6
7.7
9
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
7.7
193
1317
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
3.1
7.7
31
102
Z31.5
ICD-10 Finland
Genetic counselling
4.5
7.5
18
41
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
81.0
7.4
8
*
JFB30
NOMESCO Finland
Right hemicolectomy
13.6
7.4
12
9
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
11.0
7.3
13
12
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
7.3
7
*
PHN73
NOMESCO Finland
Reconstruction of superior mesenteric or portal vein
+∞
7.3
7
*
UJK52
NOMESCO Finland
Endoscopy of biliary tract in connection with endoscopic retrograde cholangiopancreatography
+∞
7.3
7
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
7.3
7
*
JLA00
NOMESCO Finland
Exploration of pancreas
+∞
7.3
7
*
JJC00
NOMESCO Finland
Allogenic transplantation of liver
+∞
7.3
7
*
C25.1
ICD-10 Finland
Malignant neoplasm: Body of pancreas
+∞
7.3
7
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
7.3
7
*
C25.7
ICD-10 Finland
Malignant neoplasm: Other parts of pancreas
+∞
7.3
7
*
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
+∞
7.3
7
*
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
+∞
7.3
7
*
L02BB03
ATC
bicalutamide; oral
+∞
7.3
7
*
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
3.1
7.3
30
100
GD1AD
NOMESCO Finland
Thorax CT examination
2.6
7.3
42
169
C10AX09
ATC
ezetimibe; oral
0.4
7.1
33
794
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
8.1
7.1
15
19
ZXD05
NOMESCO Finland
Urgent procedure
1.7
7.0
170
1148
OAB44, ,
SPAT
0.2
6.9
8
351
K51.1
ICD-10 Finland
Ulcerative (chronic) ileocolitis
11.1
6.8
12
11
ZX050
NOMESCO Finland
Stereotactic radiotherapy
40.5
6.8
8
*
N06DA02
ATC
donepezil; oral
0.2
6.7
8
347
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.6
6.7
271
2063
ZX090
NOMESCO Finland
Other technic of radiotherapy
22.8
6.7
9
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.0
6.7
72
378
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.7
6.7
36
140
N02AA01
ATC
morphine; systemic, rectal
5.6
6.7
18
33
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
7.9
6.6
14
18
H02AB06
ATC
prednisolone; systemic
1.6
6.6
279
2141
SPAT1262
SPAT
Handing over of treatment supplies
1.8
6.6
116
714
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.8
6.6
33
123
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.3
6.5
50
229
Z76.0
ICD-10 Finland
Issue of repeat prescription
0.5
6.5
52
1011
K31.5
ICD-10 Finland
Obstruction of duodenum
70.6
6.4
7
*
Z51.0
ICD-10 Finland
Radiotherapy session
70.6
6.4
7
*
Z80.0
ICD-10 Finland
Family history of malignant neoplasm of digestive organs
18.2
6.3
9
5
E0000UV, ,
ATC
1.6
6.3
223
1643
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
6.3
6
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
6.3
6
*
8163/3-C24.1
ICD-O-3
Pancreatobiliary type carcinoma of ampulla of Vater
+∞
6.3
6
*
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
+∞
6.3
6
*
KCC10
NOMESCO Finland
Cystoprostatectomy
+∞
6.3
6
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
6.3
6
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
6.3
6
*
JLD12
NOMESCO Finland
Endoscopic drainage of pancreatic pseudocyst
+∞
6.3
6
*
C25.3
ICD-10 Finland
Malignant neoplasm: Pancreatic duct
+∞
6.3
6
*
8010/3-C24.9
ICD-O-3
Carcinoma, NOS, of billiary tract, NOS
+∞
6.3
6
*
JFC00
NOMESCO Finland
Entero-enterostomy
+∞
6.3
6
*
JKD30
NOMESCO Finland
Extrahepatic anastomosis of right or left hepatic duct to jejunum
+∞
6.3
6
*
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
+∞
6.3
6
*
JJA20
NOMESCO Finland
Open biopsy of liver
27.0
6.2
8
*
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
27.0
6.2
8
*
Z94.4
ICD-10 Finland
Liver transplant status
27.0
6.2
8
*
A98
ICPC
Health maint/preventive medicine
0.6
6.2
449
5002
HAB40
NOMESCO Finland
Wedge excision of mammary gland
12.7
6.1
10
8
K51.5
ICD-10 Finland
Left sided colitis
3.7
6.1
19
53
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
8.7
6.1
12
14
N06DX01
ATC
memantine; oral
0.3
6.0
13
462
A10AE04
ATC
insulin glargine; parenteral
2.0
6.0
71
385
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
269
100
47.27
307.65
7.0
1.7
3305.99
13.98
u/ml
0.95
256
76
411
271
44.28
307.65
7.4
1.4
36.95
2.71
ug/l
1.91
386
201
150
17
116.62
292.75
1.4
1.1
—
—
—
0
0
250
401
9.86
163.40
5.3
1.9
0.17
0.20
g/l
6.58
237
367
262
516
8.14
140.50
8.9
2.1
47.39
7.44
umol/l
12.53
243
456
123
124
12.17
111.99
1.6
1.3
113.83
303.73
ug/g
13.77
79
76
406
1571
5.72
97.40
8.8
2.3
105.68
60.13
u/l
1.02
398
1454
249
787
4.65
72.76
4.9
2.5
0.77
0.83
mmol/l
8.25
240
726
442
2249
4.49
64.44
14.8
3.8
30.29
35.26
g/l
47.26
433
2075
338
1498
3.81
58.61
9.2
2.6
70.07
34.40
u/l
13.53
326
1404
461
2557
4.27
56.05
20.8
17.9
1.26
1.35
inr
3.77
394
2151
151
426
4.38
49.16
10.2
2.0
58.82
33.56
u/l
1.63
146
342
156
485
3.98
44.08
7.1
5.7
8.33
10.97
mmol/l
3.75
150
463
119
329
4.25
39.23
1.7
1.5
—
—
—
0
0
374
2084
3.05
39.16
4.9
2.4
—
—
estimate
—
0
0
242
1115
2.94
35.06
4.1
2.1
—
—
—
0
0
416
2550
2.98
34.93
24.4
6.1
4.62
4.37
e9/l
0.94
380
2203
87
219
4.47
32.16
2.2
1.7
4.13
1.72
ug/l
0.58
81
190
301
1691
2.54
27.88
8.4
2.1
2.33
2.35
mmol/l
2.07
291
1454
201
940
2.70
27.12
2.3
1.9
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
66
163
4.42
24.84
2.6
2.6
0.25
0.40
iu/ml
3.00
30
95
395
2622
2.43
23.96
10.5
6.1
1.18
1.21
mmol/l
5.78
335
2247
365
2349
2.38
23.63
9.5
5.7
1.18
1.21
mmol/l
6.46
353
2120
436
3055
2.49
22.96
10.9
4.7
7.34
6.86
mmol/l
4.87
428
2897
155
690
2.67
22.56
10.7
6.9
14.45
11.33
kpa
9.78
148
670
155
690
2.67
22.56
10.7
6.9
4.99
5.10
kpa
0.89
149
669
158
711
2.65
22.50
4.7
4.7
1.01
1.02
mmol/l
0.05
149
642
152
678
2.65
21.98
10.5
7.0
0.51
1.16
mmol/l
1.38
129
556
205
1092
2.32
19.89
9.3
2.2
2.51
2.45
mmol/l
6.90
196
956
167
816
2.44
19.70
2.3
2.5
2.21
2.25
g/l
0.38
161
754
24
6
41.58
19.63
1.3
3.3
8.00
8.33
ug/l
—
24
6
83
282
3.25
19.58
1.7
1.5
—
—
—
0
0
414
2951
2.25
19.17
9.1
3.1
280.85
49.72
u/l
27.27
393
2720
83
311
2.93
16.47
2.3
2.3
11.51
10.85
g/l
0.66
73
290
47
126
3.96
15.78
1.9
1.5
—
—
—
0
0
33
69
5.00
15.12
1.1
1.1
—
—
—
0
0
135
683
2.25
14.22
2.1
1.9
—
—
—
0
0
141
732
2.20
13.92
2.2
1.8
—
—
—
0
0
24
42
5.91
13.30
1.9
1.1
—
—
—
0
0
31
69
4.68
13.21
5.0
6.3
1111.86
143.78
iu/ml
—
7
9
116
2069
0.46
13.00
1.9
1.9
1.32
1.29
mmol/l
0.14
100
1708
20
13
15.85
12.69
4.0
1.2
93.15
96.54
%
0.12
20
13
27
60
4.66
11.53
1.0
1.3
168.29
178.17
au/ml
—
7
20
84
382
2.39
11.20
7.6
6.6
23.61
24.53
mmol/l
1.36
79
371
29
70
4.30
11.19
1.1
1.1
362.35
249.63
u/ml
0.60
20
30
271
1888
1.78
10.81
4.1
3.2
—
—
—
0
0
40
125
3.35
10.73
2.0
2.0
77.75
88.46
%
1.27
40
125
250
1717
1.77
10.36
4.2
3.2
36.85
103.20
e6/l
0.92
199
1317
367
4442
0.56
10.25
4.7
5.2
2.13
2.00
mu/l
0.96
314
4014
221
1481
1.77
9.86
4.2
3.1
0.66
0.46
e6/l
0.55
174
1093
13
7
18.93
8.96
2.2
2.4
0.58
0.58
mmol/l
—
13
7
402
3243
1.70
8.63
5.9
4.8
2375.00
3554.33
e6/l
—
7
55
24
62
3.99
8.49
2.3
2.0
92.24
90.16
%
1.53
24
62
400
4662
0.59
8.37
4.3
5.5
1.34
1.44
mmol/l
4.83
346
4248
21
52
4.15
7.86
1.8
2.2
—
278.14
—
0
7
104
590
1.92
7.76
3.6
3.3
1.35
2.07
mmol/l
1.07
90
512
408
4705
0.60
7.67
4.3
5.6
4.35
4.45
mmol/l
0.89
359
4322
18
27
6.83
7.64
1.2
1.0
—
—
—
0
0
419
4794
0.60
7.50
4.8
6.5
2.51
2.56
mmol/l
0.51
367
4391
403
4632
0.62
6.95
8.2
7.4
41.25
40.36
mmol/mol
1.17
369
4292
297
3652
0.64
6.94
4.1
4.0
15.14
15.04
pmol/l
0.25
250
3266
96
550
1.88
6.92
5.2
3.2
—
—
—
0
0
30
106
2.92
6.62
1.1
1.3
—
—
—
0
0
31
112
2.86
6.57
1.9
1.4
—
—
—
0
0
18
47
3.92
6.30
3.0
2.2
—
—
—
0
0
175
1219
1.61
6.24
3.7
2.5
8.21
5.12
e6/l
1.73
163
1099
32
124
2.67
5.97
3.6
2.5
1.50
1.80
mg/l
0.97
27
103
390
4471
0.65
5.96
3.9
4.7
1.27
1.27
mmol/l
0.05
339
4029
30
113
2.74
5.91
2.0
1.4
—
—
—
0
0
44
200
2.29
5.88
2.2
1.6
—
—
—
0
0
417
4707
0.64
5.84
5.0
5.7
6.21
6.10
mmol/l
1.06
370
4245
25
91
2.82
5.26
1.8
1.3
—
—
—
0
0
123
826
1.61
4.99
3.3
3.0
3.91
2.05
e6/l
0.65
63
402
35
155
2.33
4.99
1.2
1.2
—
—
—
0
0
39
183
2.21
4.86
2.1
1.5
—
—
—
0
0
12
21
5.81
4.77
5.7
2.9
3.83
1.19
index
0.91
12
21
15
43
3.55
4.64
1.5
1.0
—
—
—
0
0
15
43
3.55
4.64
1.5
1.0
—
—
—
0
0
16
48
3.40
4.63
1.4
1.0
—
—
—
0
0
24
92
2.67
4.61
1.8
1.3
—
—
—
0
0
15
37
4.13
4.43
1.4
1.5
—
—
—
0
0
20
73
2.80
4.22
2.0
1.4
—
—
—
0
0
183
1385
1.46
4.21
2.5
2.3
3.33
2.86
mg/l
0.81
163
1171
19
68
2.85
4.15
1.2
1.4
—
—
—
0
0
17
57
3.04
4.15
1.2
1.2
—
—
—
0
0
20
74
2.76
4.12
1.6
1.3
—
—
—
0
0
14
35
4.07
4.12
1.6
1.9
10.91
15.51
umol/l
1.74
14
30
25
104
2.46
4.11
1.8
1.3
—
—
—
0
0
14
42
3.39
4.06
1.5
1.0
—
—
—
0
0
50
851
0.55
4.04
1.3
1.3
54.23
38.24
iu/ml
0.26
16
255
61
360
1.77
4.00
2.0
1.6
—
—
—
0
0
15
48
3.18
3.95
1.5
1.0
—
—
—
0
0
15
48
3.18
3.95
1.5
1.0
—
—
—
0
0
14
45
3.16
3.67
3.4
2.7
724.44
595.97
ml
—
9
30
169
2139
0.71
3.50
4.5
4.4
2.11
2.03
ug/l
0.18
146
1915
14
47
3.03
3.43
1.4
1.2
21813.75
186464.22
e6/l
—
8
27
13
37
3.57
3.42
2.3
1.4
—
—
—
0
0
125
912
1.47
3.42
3.4
2.9
1.77
1.19
e6/l
0.61
66
490
132
1734
0.70
3.36
4.3
4.1
21.00
24.51
%
2.47
74
850
16
59
2.76
3.34
2.2
1.4
—
—
—
0
0
85
1213
0.65
3.32
2.8
3.0
0.64
0.78
ug/l
1.35
65
833
10
23
4.40
3.32
1.9
1.4
—
—
—
0
0
7
11
6.42
3.19
1.0
1.1
—
—
—
0
0
148
1128
1.41
3.18
4.3
4.4
606.48
413.93
ng/l
0.16
127
956
10
25
4.05
3.09
1.9
1.4
—
—
—
0
0
263
2218
1.33
2.94
4.7
4.2
27.38
99.05
ng/l
1.60
231
1722
52
804
0.61
2.90
1.3
1.3
1.37
11.89
u/ml
4.66
18
300
67
444
1.57
2.88
1.6
1.8
1.53
1.57
%
0.20
56
374
139
1770
0.72
2.87
1.9
2.3
156.92
277.41
u/l
1.66
130
1656
52
325
1.66
2.83
2.8
2.5
0.67
0.62
%
0.61
52
325
10
28
3.61
2.79
1.9
1.3
—
—
—
0
0
52
328
1.64
2.73
2.8
2.6
1.04
1.11
%
0.39
52
328
33
183
1.85
2.71
2.4
3.2
—
—
—
0
0
10
29
3.49
2.70
1.2
1.2
—
—
—
0
0
24
120
2.04
2.64
1.3
1.2
—
—
—
0
0
14
55
2.58
2.63
2.2
1.5
—
—
—
0
0
23
114
2.06
2.59
1.5
1.3
—
—
—
0
0
23
114
2.06
2.59
1.5
1.3
—
—
—
0
0
168
1353
1.33
2.52
4.6
3.5
0.03
0.00
estimate
0.44
65
403
25
130
1.96
2.49
4.9
3.9
4.00
1.29
index
0.52
20
66
168
2022
0.77
2.25
3.4
3.4
7.50
7.47
mmol/l
0.04
132
1708
5
9
5.59
2.21
1.4
1.8
2.00
1.22
%
—
5
9
424
4553
0.78
2.17
46.2
15.4
79.68
74.12
ml/min/173m2
7.17
404
4218
23
124
1.89
2.09
2.0
1.6
—
—
—
0
0
39
249
1.60
2.01
1.6
1.6
1.69
1.58
g/l
0.27
34
219
6
155
0.38
1.92
2.0
1.9
2.84
4.77
mg/l
—
6
117
46
313
1.51
1.82
4.0
3.5
2.38
2.08
mmol/l
0.13
31
228
7
23
3.07
1.80
2.0
1.4
—
—
—
0
0
30
187
1.64
1.72
1.4
2.3
43.71
40.68
u/l
0.34
24
158
227
1986
1.23
1.65
5.0
4.1
0.00
0.01
estimate
0.78
71
421
175
2032
0.81
1.64
4.5
4.2
8.51
8.66
mg/mmol
0.02
109
1295
486
5085
0.78
1.61
65.4
23.9
118.51
135.34
g/l
91.59
479
5005
13
63
2.09
1.60
1.0
1.3
—
—
—
0
0
486
5084
0.78
1.60
64.8
23.7
4.02
4.47
e12/l
56.44
477
4932
486
5084
0.78
1.60
66.9
24.2
35.48
40.29
%
55.84
478
5001
486
5083
0.79
1.58
64.7
23.7
91.16
91.68
fl
1.70
480
5004
486
5083
0.79
1.58
64.9
23.7
256.80
239.89
e9/l
5.18
477
4951
7
26
2.71
1.58
2.9
2.5
—
—
—
0
0
11
50
2.22
1.57
1.7
1.4
6.92
8.12
mmol/l
0.88
11
50
6
142
0.42
1.54
1.2
1.2
—
2.71
—
0
17
6
143
0.41
1.53
1.2
1.2
—
4.35
—
0
23
19
318
0.58
1.52
2.1
2.7
—
15.71
—
0
17
5
125
0.40
1.51
1.0
1.2
—
10.71
—
0
9
14
73
1.94
1.45
2.1
1.4
—
—
—
0
0
17
287
0.58
1.41
1.1
1.4
—
51.06
—
0
22
240
2138
1.20
1.41
3.0
3.0
198.81
134.92
ug/l
2.90
228
1962
5
17
2.96
1.36
1.0
1.1
—
—
—
0
0
5
17
2.96
1.36
1.0
1.2
—
—
—
0
0
5
17
2.96
1.36
1.0
1.1
—
—
—
0
0
286
2600
1.19
1.32
4.6
4.0
0.00
0.00
estimate
-0.00
78
524
290
2644
1.18
1.29
4.7
4.0
0.00
0.00
estimate
-0.00
80
539
290
2651
1.18
1.23
4.7
4.0
0.04
0.01
estimate
0.30
76
506
485
5042
0.82
1.22
57.8
21.2
77.14
82.81
umol/l
3.95
479
4966
8
37
2.18
1.21
1.0
1.0
—
—
—
0
0
8
38
2.12
1.18
1.3
1.3
106.88
45.54
u/l
—
8
31
8
39
2.06
1.15
1.4
1.1
—
—
—
0
0
8
39
2.06
1.15
1.4
1.1
—
—
—
0
0
8
39
2.06
1.15
1.4
1.1
—
—
—
0
0
0
36
0.00
1.14
0.0
1.4
—
90.64
—
0
36
8
41
1.96
1.09
1.4
1.3
—
—
—
0
0
13
213
0.60
1.01
1.6
1.7
—
—
—
0
0
5
109
0.45
1.01
1.8
1.1
—
75.86
—
0
10
7
131
0.53
1.00
1.0
1.2
—
—
—
0
0
43
328
1.33
0.99
5.5
3.5
40.39
47.12
%
1.02
43
321
53
664
0.78
0.97
4.3
5.5
32.79
32.62
%
0.03
33
410
6
27
2.23
0.93
1.0
1.3
—
—
—
0
0
21
143
1.49
0.91
3.2
2.2
121.69
131.80
g/l
1.28
16
114
216
1968
1.15
0.90
3.7
3.2
1489.87
1665.80
ng/l
0.25
193
1698
84
991
0.82
0.90
1.3
1.3
1.54
1.50
u/ml
0.02
17
287
9
152
0.59
0.89
1.4
1.3
—
—
—
0
0
154
1721
0.86
0.88
1.9
1.7
20.61
20.18
nmol/l
0.14
144
1442
8
44
1.83
0.86
1.4
1.3
—
—
—
0
0
57
464
1.25
0.83
2.6
2.3
1.44
0.38
e6/l
1.16
57
432
12
188
0.63
0.81
1.5
1.6
—
—
—
0
0
0
24
0.00
0.79
0.0
7.8
—
38.13
—
0
8
0
25
0.00
0.79
0.0
1.2
—
—
—
0
0
0
26
0.00
0.78
0.0
1.0
—
—
—
0
0
118
1039
1.17
0.78
2.7
1.6
3.57
1.36
mg/l
2.23
103
809
481
4654
1.16
0.77
49.1
15.7
43.34
25.58
mg/l
20.96
472
3828
15
99
1.53
0.76
1.0
1.3
—
—
—
0
0
29
379
0.75
0.75
1.9
2.6
14.14
15.21
nmol/l
0.20
24
344
13
196
0.66
0.75
1.1
1.1
—
—
—
0
0
8
135
0.59
0.74
1.1
1.3
581.25
520.76
mg/l
—
8
127
166
1507
1.14
0.73
5.3
4.1
0.00
0.00
estimate
-0.00
63
482
33
420
0.77
0.71
1.2
1.5
—
—
—
0
0
22
160
1.39
0.71
3.7
2.4
74.46
95.94
ug/min
0.24
13
96
482
4954
0.87
0.68
36.6
10.6
43.31
25.24
u/l
21.27
477
4752
0
23
0.00
0.58
0.0
1.1
—
1.10
—
0
13
6
100
0.60
0.52
2.2
1.2
0.94
0.91
g/l
—
6
100
485
4960
0.89
0.52
52.6
20.2
3.94
4.01
mmol/l
7.25
479
4848
48
408
1.19
0.51
3.8
2.4
60.99
60.87
ml/min/173m2
0.01
19
172
53
455
1.18
0.51
2.6
1.8
418.17
368.59
nmol/l
0.97
48
417
11
75
1.48
0.51
3.9
2.4
1.21
1.19
mmol/l
0.33
11
75
59
675
0.86
0.49
13.3
7.3
—
—
—
0
0
485
4955
0.90
0.48
52.4
20.1
137.54
139.79
mmol/l
42.77
479
4851
11
77
1.44
0.46
3.9
2.4
4.10
4.13
mmol/l
0.08
11
77
11
77
1.44
0.46
3.9
2.4
105.91
105.47
mmol/l
0.12
11
77
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
127
1367
0.91
0.40
2.8
2.5
366.05
360.94
umol/l
0.18
108
1165
5
34
1.47
0.40
1.0
1.1
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
14.58
—
0
10
242
2532
0.93
0.39
2.2
2.2
88.91
94.84
pmol/l
1.25
141
1326
7
105
0.66
0.39
1.4
1.5
—
—
—
0
0
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
0
19
0.00
0.39
0.0
1.3
—
9.16
—
0
19
8
115
0.69
0.37
1.1
1.3
4.60
3.94
mmol/l
—
8
108
5
37
1.35
0.37
1.0
1.1
—
—
—
0
0
5
37
1.35
0.37
1.0
1.1
—
—
—
0
0
6
44
1.37
0.34
1.0
1.1
—
—
—
0
0
11
144
0.76
0.33
1.7
1.5
11129.20
13812.84
e6/l
—
5
100
12
94
1.28
0.28
1.1
1.3
—
—
—
0
0
10
128
0.78
0.27
2.0
1.8
—
—
—
0
0
12
96
1.26
0.24
1.0
1.1
—
3.99
—
0
12
5
42
1.19
0.21
1.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
0.16
—
0
11
0
10
0.00
0.21
0.0
1.5
—
46.79
—
0
10
0
10
0.00
0.21
0.0
1.0
—
1.19
—
0
10
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
21
183
1.15
0.20
2.1
1.6
0.18
0.29
mg/l
—
7
81
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
6
50
1.20
0.19
1.0
1.1
—
—
—
0
0
19
165
1.16
0.19
4.6
1.2
2.79
1.38
ratio
—
9
103
40
432
0.92
0.16
1.4
1.5
—
—
—
0
0
127
1224
1.05
0.16
4.9
4.4
1.02
1.02
kg/l
0.11
92
802
14
122
1.15
0.14
1.4
1.4
—
—
—
0
0
111
1071
1.04
0.13
1.9
1.8
1296.61
1195.43
nmol/l
0.53
92
809
128
1240
1.04
0.13
1.8
1.8
199091462.20
19062314.04
pmol/l
0.60
110
1002
21
231
0.91
0.12
1.1
1.2
402.86
96.59
u/ml
—
7
92
238
2341
1.03
0.10
2.8
2.4
—
—
—
0
0
11
125
0.88
0.10
1.1
1.2
—
—
—
0
0
11
124
0.89
0.09
1.1
1.2
—
—
—
0
0
5
63
0.79
0.08
1.4
1.1
—
—
—
0
0
18
166
1.09
0.08
1.3
1.3
—
—
—
0
0
6
75
0.80
0.07
1.3
1.5
0.55
25.36
nmol/l
—
6
69
54
521
1.04
0.07
1.3
1.4
—
—
—
0
0
227
2242
1.02
0.07
2.6
2.4
69.64
79.49
nmol/l
5.97
215
1961
380
3773
1.02
0.06
57.1
19.2
15.08
13.69
%
45.14
380
3707
13
120
1.09
0.05
2.4
1.5
—
—
—
0
0
16
150
1.07
0.04
3.2
3.7
0.75
0.86
nmol/l
—
10
128
364
3659
0.99
0.04
4.6
4.4
23.71
12.74
mm/h
15.02
338
3367
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
105.67
—
0
6
0
7
0.00
-0.00
0.0
1.3
—
15.16
—
0
7
0
8
0.00
-0.00
0.0
1.0
—
59.51
—
0
8
0
7
0.00
-0.00
0.0
10.1
—
4.74
—
0
7
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
6
66
0.91
-0.00
4.5
3.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
6.40
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
5
56
0.89
-0.00
1.0
1.2
—
19.99
—
0
15
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_BILIARY_TRACT – Malignant neoplasm of other and unspecified parts of biliary tract
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).